Facebook tracking pixel

Coming Soon

S10.AI's Next-Generation Telehealth Platform

E04.2
ICD-10-CM
Multiple Thyroid Nodules

Find comprehensive information on multiple thyroid nodules including diagnosis, ICD-10 codes (E04.2, E04.9), clinical documentation requirements, differential diagnosis, ultrasound findings, and thyroid nodule management. Learn about fine needle aspiration biopsy (FNAB), thyroidectomy, and the role of healthcare professionals in evaluating and treating patients with multiple thyroid nodules. This resource provides valuable insights for physicians, nurses, coders, and other healthcare providers involved in the care of patients with this condition.

Also known as

Multinodular Goiter
Thyroid Nodules

Diagnosis Snapshot

Key Facts
  • Definition : Presence of two or more abnormal growths within the thyroid gland.
  • Clinical Signs : Often asymptomatic. May cause neck swelling, discomfort, or difficulty swallowing if large.
  • Common Settings : Primary care, endocrinology clinics, diagnostic imaging centers.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC E04.2 Coding
E05.1

Thyrotoxicosis with diffuse goiter

Overactive thyroid with enlarged gland, sometimes with nodules.

E04.2

Nontoxic multinodular goiter

Enlarged thyroid with multiple nodules, but normal thyroid function.

E04.9

Goiter, unspecified

Enlarged thyroid without specifying the cause or type.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Are any nodules biopsied?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Multiple Thyroid Nodules
Thyroid Cyst
Dominant Thyroid Nodule

Documentation Best Practices

Documentation Checklist
  • Thyroid nodule size, number, location documented.
  • TSH, T3, T4 levels recorded.
  • Ultrasound findings detailed (e.g., echogenicity).
  • FNA biopsy results if performed (Bethesda category).
  • Patient symptoms (e.g., dysphagia, voice changes).

Coding and Audit Risks

Common Risks
  • Unspecified Nodule Type

    Coding lacks specificity (e.g., using E04.9 instead of E04.0 or E04.2) impacting reimbursement and data accuracy. CDI can clarify.

  • Missed Dominant Nodule

    Largest nodule not identified impacting risk assessment and treatment. CDI should query for presence and size of all nodules.

  • Inconsistent Documentation

    Discrepancy between imaging reports and physician notes creates coding and billing errors. CDI reconciliation is crucial.

Mitigation Tips

Best Practices
  • ICD-10 E04.2 accurate coding for multinodular goiter. CDI crucial.
  • Detailed US features, nodule size key for FNA decision, avoid HCC risks.
  • Thyroid function tests essential, document TSH, T3, T4 for compliance.
  • Correlate cytology with imaging. Thorough documentation for HCC avoidance.
  • Monitor nodule growth. Clear US reports, avoid malpractice, ensure compliance.

Clinical Decision Support

Checklist
  • Confirm thyroid ultrasound shows 2+ nodules
  • Evaluate TSH, T3, T4 levels
  • Review family history of thyroid cancer
  • Document nodule size, location, characteristics
  • Consider FNA biopsy if indicated by guidelines

Reimbursement and Quality Metrics

Impact Summary
  • Multiple Thyroid Nodules: Reimbursement and Quality Metrics Impact Summary
  • Keywords: ICD-10 E04.2, thyroid nodule billing, coding accuracy, hospital quality reporting, physician documentation, risk adjustment, HCC coding, RAF score
  • Impact 1: Accurate E04.2 coding maximizes reimbursement for evaluation and management services.
  • Impact 2: Proper documentation of nodule size and characteristics impacts risk adjustment and HCC coding.
  • Impact 3: Thyroid nodule diagnosis influences quality metrics related to diagnostic imaging utilization.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: How can I differentiate between benign and malignant multiple thyroid nodules using ultrasound features and fine-needle aspiration biopsy (FNAB) results?

A: Differentiating benign from malignant multiple thyroid nodules requires a combination of ultrasound assessment and FNAB cytology. Ultrasound features suggestive of malignancy include hypoechogenicity, microcalcifications, irregular margins, taller-than-wide shape, and increased vascularity. While these features can raise suspicion, they are not definitive. FNAB is crucial for obtaining a cytological diagnosis. The Bethesda System for Reporting Thyroid Cytopathology provides a standardized framework for classifying FNAB results, ranging from benign to malignant. Bethesda category II (benign) typically warrants observation, while categories V and VI (suspicious for or diagnostic of malignancy) necessitate surgical intervention. Categories III and IV require further evaluation, potentially including molecular testing or repeat FNAB. Consider implementing a standardized protocol for thyroid nodule evaluation incorporating both ultrasound and FNAB findings to improve diagnostic accuracy. Explore how molecular markers can further enhance risk stratification for indeterminate cytology results.

Q: When should I consider surgical intervention for multiple thyroid nodules in a patient with elevated thyroid stimulating hormone (TSH), and what are the key surgical approaches?

A: Elevated TSH in a patient with multiple thyroid nodules suggests the possibility of a multinodular goiter with underlying hypothyroidism. Surgical intervention for multiple thyroid nodules in the setting of elevated TSH is generally reserved for cases with compressive symptoms (dysphagia, dyspnea), suspicion of malignancy based on ultrasound and/or FNAB findings, or significant cosmetic concerns. The primary surgical approaches include total thyroidectomy or subtotal thyroidectomy. Total thyroidectomy is often preferred as it eliminates the risk of recurrence in the remaining thyroid tissue and simplifies long-term monitoring for thyroid cancer. Subtotal thyroidectomy may be considered in select cases with lower risk of malignancy and strong patient preference for preserving thyroid function. Learn more about the potential complications and long-term management of patients undergoing thyroidectomy for multiple thyroid nodules.

Quick Tips

Practical Coding Tips
  • Code E04.2 for toxic multinodular goiter
  • Code E04.9 for nontoxic multinodular goiter
  • Document nodule size and characteristics
  • Consider FNA biopsy coding
  • Exclude malignancy with appropriate ICD-10

Documentation Templates

Patient presents with complaints potentially indicative of multiple thyroid nodules.  Symptoms reported include palpable thyroid lump, neck swelling, dysphagia, dysphonia, and occasional sensation of tightness in the throat.  Physical examination revealed multiple palpable nodules on the thyroid gland, without overt signs of thyroid dysfunction.  The patient denies pain, fever, or recent upper respiratory infection.  Family history is significant for hypothyroidism in the mother and goiter in a paternal aunt.  Differential diagnosis includes multinodular goiter, thyroid adenoma, and thyroid cancer.  Given the presence of multiple thyroid nodules, thyroid ultrasound is indicated for further evaluation of nodule size, number, and characteristics.  Thyroid function tests, including TSH, free T4, and free T3, will be ordered to assess thyroid hormone levels.  Fine needle aspiration biopsy may be considered depending on ultrasound findings and thyroid function test results.  Patient education provided regarding the importance of follow-up and potential treatment options including observation, medication management, or surgical intervention depending on final diagnosis and clinical course.  ICD-10 code E04.2, multinodular goiter, is provisionally assigned pending further diagnostic evaluation.  CPT codes for ultrasound and potential biopsy will be assigned upon procedure completion.  Patient will be scheduled for a follow-up appointment to review results and discuss next steps in management.